-transparent.png){kind=logo}
Although histamine plays an important role in the pathophysiology of asthma through stimulation of H1 receptors, H1 antagonists are of only limited use in this disease when given orally. In order to investigate the pharmacological response to a specific H1 antagonist administered by different routes, we measured the effect of inhaled clemastine on airway responsiveness to histamine aerosol and compared the results with those after oral and intravenous administration in normal and asthmatic subjects. Inhalation of 0.6 mg clemastine provided significant protection without side effects and was comparable to intravenous administration of 1.0 mg in both groups. In normal subjects 2.0 mg clemastine orally was significantly less effective than the two other routes of administration whereas in asthmatics an enhanced reaction to histamine was observed.
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
September 1985,
European journal of respiratory diseases,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
April 1987,
Allergy,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
October 1989,
Chest,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
October 1996,
American journal of respiratory and critical care medicine,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
May 1994,
American journal of respiratory and critical care medicine,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
November 1996,
Chest,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
June 1988,
The American review of respiratory disease,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
April 1983,
The Journal of allergy and clinical immunology,
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
October 1987,
Journal of applied physiology (Bethesda, Md. : 1985),
V Hartmann, and
H Magnussen, and
J P Holle, and
E Schüler
April 1989,
The European respiratory journal,
